[ Price : $8.95]
FDA approves Tenpoint Therapeutics Yuvezzi as the only combination eye drop approved to treat presbyopia in adults.[ Price : $8.95]
FDA posts an updated guidance clarifying when clinical decision support software functions fall outside the definition of a regula...[ Price : $8.95]
An industry consultant says reduced FDA staffing levels and high turnover are extending regulatory timelines and forcing drug deve...[ Price : $8.95]
Axios reports that the vice chair of the CDC Advisory Committee on Immunization Practices says the Pfizer and Moderna Covid mRNA v...[ Price : $8.95]
CDRH reports on its 2025 MDUFA 5 activities to promote international harmonization.[ Price : $8.95]
A Congressional Research Service backgrounder explains options Congress could consider to resolve some issues with the skinny labe...[ Price : $8.95]
FDA accepts for review a Summit Therapeutics BLA seeking approval for ivonescimab in combination with chemotherapy in patients wit...[ Price : $8.95]
Boehringer Ingelheim says its investigational kidney drug apecotrep reduced proteinuria by 40% compared with placebo in a Phase 2 ...